Cannabis consumers tend to be a little leaner than those who don’t use the drug, and a group of researchers may have just figured out why.
The Colorado Department of Revenue said that it had been made aware of “adverse health events” related to 1906 Midnight Drops, a cannabis-infused edible marketed as a sleep aid.
A group of researchers at Cornell University, New York, have been awarded a $11.6 million grant to study how cannabis affects the brains of HIV patients.
Michael Sassano, CEO of Somai Pharmaceuticals, takes a look into the future of Germany's cannabis marketplace.
Analytical Cannabis spoke with Deepank Utkhede, chief operating officer at the pharmaceutical-grade CBD producer Vantage Hemp, to learn exactly how to turn hemp into an extract.
The study involved over 300 chronic pain patients who received more than one infusion of ketamine over several months. All participants reported pain relief; those with depression experienced “more robust” relief.
The report, published in the journal Drug Science, Policy and Law, details the experiences of a 35-year-old man who had been diagnosed with a mild case of red-green color blindness five years earlier.
In the second episode of Analytical Cannabis' new video series, The Cannabis Industry Needs..., A2LA's Morgan Keefer explains why the the industry can benefit from more stringent proficiency testing and regular interlaboratory check-ins.